NIH-funded research R37 grant

Understanding how LSD affects serotonin receptors in the brain

Official title: Mechanistic insights into LSD actions at 5-HT2A serotonin receptors

Funded at Univ of North Carolina Chapel Hill · NIH-11036392 · Data updated 2026-11-12

This study is looking at how LSD and similar psychedelic drugs work in the brain by exploring their effects on serotonin receptors, which could help us understand how these substances might impact mental health and behavior.

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startMarch 1, 2023
Project endFebruary 29, 2028
Funding year2025
Award (this year)$650,756
NIH project number5R37DA045657-08
Project IDNIH-11036392 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals experiencing anxiety or other mental health issues who may benefit from novel therapeutic approaches.

Less likely to help

Patients who do not have any mental health conditions or those who are not interested in psychedelic treatments may not receive benefit from this research.

What this research studies

This research investigates the molecular mechanisms by which LSD and similar psychedelic drugs interact with serotonin receptors in the brain. By studying both human and rodent receptors, the research aims to uncover how these substances influence gene transcription in neurons. The approach includes in vitro and in vivo experiments to provide detailed insights into the actions of these drugs at the molecular level. This could lead to a better understanding of the effects of psychedelics on mental health and behavior.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for anxiety and other mental health conditions by leveraging the effects of psychedelics.

How similar studies have gone: Other research has shown promising results in understanding the therapeutic potential of psychedelics, indicating that this approach is building on a growing body of evidence.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Roth, Bryan L. — Univ of North Carolina Chapel Hill
  • Study coordinator: Roth, Bryan L.

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.